LEUNG GABRIEL 4
4 · NovoCure Ltd · Filed Aug 6, 2021
Insider Transaction Report
Form 4
NovoCure LtdNVCR
LEUNG GABRIEL
Director
Transactions
- Sale
Ordinary Shares
2021-08-05$152.50/sh−1,000$152,500→ 72,859 total - Exercise/Conversion
Ordinary Shares
2021-08-05$31.45/sh+1,000$31,450→ 73,859 total - Exercise/Conversion
Options to Buy Ordinary Shares
2021-08-05−1,000→ 2,345 totalExercise: $31.45Exp: 2028-05-30→ Ordinary Shares (1,000 underlying)
Footnotes (2)
- [F1]Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung.
- [F2]Fully vested as of the date hereof.